Figure 2. bNED survival of favorable vs. unfavorable group. Patients were divided in two prognostic groups: a favorable group with PSA <= 10, Gleason score < 7, and T1-T2 tumors, and an unfavorable group with PSA > 10, Gleason score >= 7 or T3-T4 tumors.